**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 138977-28-3 |Capsazepine | | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. The toxicological properties of this substance
have not been fully investigated.
Inhalation:
Harmful if inhaled. The toxicological properties of this substance
have not been fully investigated.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin
and eyes.
Storage:
Store in a tightly closed container. Store in a dry area. Keep
refrigerated. (Store below 4C/39F.)
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 138977-28-3:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C19H21ClN2O2S
Molecular Weight: 376.6722
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, oxides of nitrogen, oxides of
sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 138977-28-3: CX7075000
LD50/LC50:
Not available.
Carcinogenicity:
Capsazepine -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 138977-28-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 138977-28-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 138977-28-3 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 1/22/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Methyl methacrylate, 99+% (GC)
| 80-62-6 |
|
Bicine, Biograde
| 150-25-4 |
|
Methyl P-Hydroxybenzoate, 99% (Titr.)
| 99-76-3 |
|
Methyl Red, reagent ACS
| 493-52-7 |
|
Methyl Salicylate, 99+%
| 119-36-8 |
|
Triethylphenylammonium iodide, 99% (titr.)
| 1010-19-1 |
|
CAPS, BioGRADE
| 1135-40-6 |
|
1,6-Dibromohexane, 98%
| 629-03-8 |
|
tert-Butyl methyl ether, 99%
| 1634-04-4 |
|
MES monohydrate
| 4432-31-9 |
|
Aluminum sulfate
| 10043-01-3 |
|
Aluminum sulfate octadecahydrate
| 7784-31-8 |
|
Dimethoxymethane, 99.5+%
| 109-87-5 |
|
Methylamine, 40 wt. % solution in water
| 74-89-5 |
|
TAPS, Biograde
| 29915-38-6 |
|
TRICINE, BioGRADE
| 5704-04-1 |
|
Acetone, Electronic Use Grade, Residue Free
| 67-64-1 |
|
Butyl acetate Electronic use grade, residue free
| 123-86-4 |
|
1,2-Dichloroethane, electronic use grade, residue free
| 107-06-2 |
|
Dichloromethane, Stabilized, Electronic Use Grade, Residue Free
| 75-09-2 |
|
Ethyl Acetate, Electronic use Grade, Residue Free
| 141-78-6 |
|
N-Hexane, Electronic Use Grade, Residue Free
| 110-54-3 |
|
Methyl alcohol, electronic use grade, residue free
| 67-56-1 |
|
2-Butanone, Electronic Use Grade, Residue Free
| 78-93-3 |
|
4-Methyl-2-Pentanone, Electronic Use Grade, Residue Free
| 108-10-1 |
|
Isopropanol, Electronic use Grade, Residue Free
| 67-63-0 |
|
Xylenes mixed, electronic use grade, residue free
| 1330-20-7 |
|
5-Fluorocytosine, 98%
| 2022-85-7 |
|
A23187 (Free Acid)
| 52665-69-7 |
|
A23187(Mixed Calcium-Magnesium Salt)
| 52665-69-7 |
|
Aluminum (Metallic, Powder)
| 7429-90-5 |
|
A23187, 4-Bromo
| 76455-82-8 |
|
Hydroxyurea, 98%
| 127-07-1 |
|
AEBSF Hydrochloride
| 30827-99-7 |
|
Calmidazolium chloride
| 57265-65-3 |
|
Calpain Inhibitor I
| 110044-82-1 |
|
Calpain Inhibitor II
| 136632-32-1 |
|
Calpeptin
| 117591-20-5 |
|
Calphostin C
| 121263-19-2 |
|
Capsazepine
| 138977-28-3 |
|
Creatine Phosphate Disodium Salt Tetrahydrate, 99%
| 922-32-7 |
|
D-LUCIFERIN
| 2591-17-5 |
|
D-LUCIFERIN SODIUM SALT MONOHYDRATE
| 103404-75-7 |
|
4-Nitrophenyl-Beta-D-Glucuronide
| 10344-94-2 |
|
4-NITROPHENYL-ALPHA-D-MANNOPYRANOSIDE HYDRATE, 99%
| 10357-27-4 |
|
Dichloromethane, CP, Stabilized With ca 0.2% Ethanol
| 75-09-2 |
|
Tris(2-butoxyethyl)phosphate 98%
| 78-51-3 |
|
D-Ribose-5-Phosphate Disodium Salt Hydrate, 95%
| 18265-46-8 |
|
Diiodomethane, 99+%
| 75-11-6 |
|
2-Phenylethyl-Beta-D-Thiogalactoside
| 63407-54-5 |
|
|